Market revenue in 2023 | USD 74.2 million |
Market revenue in 2030 | USD 251.5 million |
Growth rate | 19% (CAGR from 2023 to 2030) |
Largest segment | Adeno-associated virus (aav) |
Fastest growing segment | Adeno-associated virus (AAV) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Adeno-associated virus (AAV), Lentivirus, Adenovirus, Retrovirus, Plasmids |
Key market players worldwide | Merck KGaA, Lonza Group Ltd, FUJIFILM Holdings Corp, Thermo Fisher Scientific Inc, Catalent Inc, WuXi Biologics (Cayman) Inc, Takara Bio Inc, Batavia Biosciences, Miltenyi Biotec, Revvity Inc, BioNTech SE ADR, Astellas Pharma Inc, Biomarin Pharmaceutical Inc, Regenxbio Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vector and plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Adeno-associated virus (aav) was the largest segment with a revenue share of 20.35% in 2023. Horizon Databook has segmented the Denmark viral vector and plasmid dna manufacturing market based on adeno-associated virus (aav), lentivirus, adenovirus, retrovirus, plasmids covering the revenue growth of each sub-segment from 2018 to 2030.
According to the World Population Review, Denmark was ranked 5th globally in terms of the number of cancer cases in 2022.
In 2020, around 334.9 people per 100,000 in Denmark had cancer, which has led to a high demand for advanced therapeutics like gene therapy and cancer vaccines.
The country’s market is primarily driven by increased demand for precision medicine, rising R&D expenditure by biopharmaceutical companies, and an evolving biotechnology sector.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark viral vector and plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Denmark viral vector and plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account